Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Proliferative Diabetic Retinopathy”

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07592273
What this trial is testing

Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema

Who this might be right for
Diabetic Retinopathy
AbbVie 576
Not applicableEnded earlyNCT03242031
What this trial is testing

Medico-economic Comparison Between Treatment with Panretinal Photocoagulation by Laser in 1 Session Versus 4 Sessions in Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Centre Hospitalier Universitaire Dijon 48
Testing effectiveness (Phase 2)Study completedNCT02435862
What this trial is testing

A Clinical Trial Designed to Evaluate the Safety and Efficacy Study of Luminate® in Inducing PVD (Posterior Vitreous Detachment) in Non-Proliferative Diabetic Retinopathy

Who this might be right for
Non-Proliferative Diabetic Retinopathy
Allegro Ophthalmics, LLC 105
Large-scale testing (Phase 3)UnknownNCT04511715
What this trial is testing

Intravitreal Bevacizumab for Nonproliferative Diabetic Retinopathy

Who this might be right for
Non-proliferative Diabetic Retinopathy
Shahid Beheshti University of Medical Sciences 100
Testing effectiveness (Phase 2)Study completedNCT03197870
What this trial is testing

The TIME-2b Study: A Study of AKB-9778 (Razuprotafib), a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR)

Who this might be right for
Nonproliferative Diabetic Retinopathy
EyePoint Pharmaceuticals, Inc. 167
Post-approval studies (Phase 4)UnknownNCT05358080
What this trial is testing

Study to Evaluate Efficacy and Safety of Entelon 50mg in Patients With Non-Proliferative Diabetic Retinopathy

Who this might be right for
Non Proliferative Diabetic Retinopathy
Hanlim Pharm. Co., Ltd. 396
Testing effectiveness (Phase 2)UnknownNCT05393284
What this trial is testing

Phase 2 Spectra Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy

Who this might be right for
Non-proliferative Diabetic RetinopathyProliferative Diabetic Retinopathy
Valo Health, Inc. 114
Not applicableUnknownNCT01759121
What this trial is testing

Safety and Effectiveness Study of 532nm Laser Subthreshold Panretinal Photocoagulation for Severe NPDR

Who this might be right for
Severe Non-proliferative Diabetic Retinopathy
Sun Yat-sen University 84
Testing effectiveness (Phase 2)Study completedNCT05681884
What this trial is testing

Safety and Efficacy of Faricimab in Patients With NPDR

Who this might be right for
Non-Proliferative Diabetic Retinopathy
Greater Houston Retina Research 179
Testing effectiveness (Phase 2)UnknownNCT04782128
What this trial is testing

Evaluation of RC28-E Injection in Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
RemeGen Co., Ltd. 120
Large-scale testing (Phase 3)Study completedNCT01872611
What this trial is testing

Nepafenac Once Daily for Macular Edema - Study 2

Who this might be right for
Non-Proliferative Diabetic RetinopathyCataract
Alcon Research 819
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07236645
What this trial is testing

Efficacy and Safety of Ginkgo Biloba Extract EGb761® in Patients With Diabetic Retinopathy

Who this might be right for
Non-proliferative Diabetic Retinopathy (NPDR)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 200
Not applicableStudy completedNCT01646047
What this trial is testing

Diabetes Visual Function Supplement Study

Who this might be right for
Diabetes Mellitus - Type 1Diabetes Mellitus - Type 2Non-proliferative Diabetic Retinopathy
ZeaVision, LLC 70
Large-scale testing (Phase 3)UnknownNCT00908778
What this trial is testing

A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects

Who this might be right for
Diabetic Retinopathy
Vitreoretinal Technologies, Inc. 160
Testing effectiveness (Phase 2)Study completedNCT02062034
What this trial is testing

Efficacy of Ubiquinone and Combined Antioxidant Therapy in Non-proliferative Diabetic Retinopathy

Who this might be right for
Non-proliferative Diabetic RetinopathyDiabetes Mellitus Type 2
University of Guadalajara 61
Post-approval studies (Phase 4)Looking for participantsNCT06662994
What this trial is testing

High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous Vitrectomy

Who this might be right for
Diabetic Macular Edema (DME)
Retina Consultants of Orange County 15
Large-scale testing (Phase 3)Study completedNCT01853072
What this trial is testing

Nepafenac Once Daily for Macular Edema - Study 1

Who this might be right for
Non-Proliferative Diabetic RetinopathyCataract
Alcon Research 881
Testing effectiveness (Phase 2)Study completedNCT01295775
What this trial is testing

Diabetic Retinopathy Sulodexide Study

Who this might be right for
Diabetic Retinopathy
Ajou University School of Medicine 127
Large-scale testing (Phase 3)Ended earlyNCT00248131
What this trial is testing

Extension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Novartis Pharmaceuticals 260
Testing effectiveness (Phase 2)Study completedNCT02863354
What this trial is testing

Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy

Who this might be right for
Proliferative Diabetic Retinopathy
Charles C Wykoff, PhD, MD 43
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation